http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-100248-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
filingDate 2008-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc0874055834cf059b7d851a2aaad3df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fa8f4463ca25a525b124a45bf0ff9c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2143a18d773d34fb30320cc8df0aa7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6119db2e854db4747b2004f673372c52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ecd88aefbc315b024c8828b7695d076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d04589e4c6b8822759f828f83a4a88e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9632b0a499b4f3efe3b8397284d39a99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fcfac2553193126bb9905d5e08ce529
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef2e420ae39a2ec6c013b037816d39e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef56572fb334e76e16033ae6933f9a72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_921b7e38392116cd0282043ed6fb9f15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c422ce9489d233f7e2b3342f0f138396
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_695f1adbd75503776fa6c585b0f38059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3e4c021de2278cf6473e0c6f1fd5d40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d8960f0ce3a1605f827c4e5bee4794d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2367a6f52439230a9872113aa9a0cbbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0e8cd518757fcdf6798b20353e8f00d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52ff35d803bf0f9e43c22ac38e22d6b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c8e9aabeee4a20c6f6eb838d2c394c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a31807946b8542090cbc2f19f34b198
publicationDate 2012-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-100248-C2
titleOfInvention HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING IT
abstract The present invention relates to a heterocyclic compound represented by the general Formula (1): EMBED ISISServer, (1) in which R is a R5-Z1- group, etc., Z1 is a lower alkylene group, etc., and R5 is a group. represented by the general Formula: EMBED ISISServer, in which R13 is a hydrogen atom, etc., m is an integer from 1 to 5; R represents a hydrogen atom; Y is CH or N; A1 means a heterocyclic ring selected from the group consisting of indole moieties, wherein the heterocyclic ring may have at least one substituent; T stands for -CO- group, etc .; R3 denotes a hydrogen atom, etc .; R4 means a lower alkyl group optionally substituted by one or more hydroxyl groups, etc .; R3 and R4, together with the nitrogen atom to which they are attached, can be bonded to each other and form a 5-10 membered saturated heterocyclic ring, and the heterocyclic ring may have at least one substituent. The heterocyclic compound of the present invention has excellent effects on the inhibition of collagen production and / or the treatment of tumors.
priorityDate 2007-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4363005
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565413
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565880
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33727
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID173839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 55.